Signals of interstitial lung disease with novel antineoplastic agents in ovarian cancer: a three-database disproportionality study
Patients with ovarian cancer administrating mirvetuximab soravtansine-gynx or olaparib merit close monitor for ILD. Early detection and immediate intervention are critical.
Authors
- X. J. Chen
- Xialing Zhu
- Xuan Song
- Chenguang Yang
- Min Chen
- Zhongjian Wang
- Chengjiang Liu
- Hongmei Sun
Institutions
- Anhui Medical University (CN)
- Sichuan Conservatory of Music (CN)
- Beijing Xuanwu Traditional Chinese Medicine Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.3389/fphar.2025.1682276
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00